These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35434388)

  • 21. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
    Sood A; Shukla J; Shree R; Vatsa R; Modi M; Mittal BR
    Clin Nucl Med; 2021 Feb; 46(2):95-102. PubMed ID: 33234920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Lee CS; Kim JS
    Nucl Med Mol Imaging; 2013 Mar; 47(1):44-51. PubMed ID: 24895507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns' based approach.
    Rus T; Tomše P; Jensterle L; Grmek M; Pirtošek Z; Eidelberg D; Tang C; Trošt M
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2901-2910. PubMed ID: 32337633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.
    Garraux G; Phillips C; Schrouff J; Kreisler A; Lemaire C; Degueldre C; Delcour C; Hustinx R; Luxen A; Destée A; Salmon E
    Neuroimage Clin; 2013; 2():883-93. PubMed ID: 24179839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
    Burn DJ; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.
    Zhao P; Zhang B; Gao S; Li X
    Brain Behav; 2020 Nov; 10(11):e01827. PubMed ID: 32940411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET and the investigation of dementia in the parkinsonian patient.
    Turjanski N; Brooks DJ
    J Neural Transm Suppl; 1997; 51():37-48. PubMed ID: 9470127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism.
    Kathuria H; Mehta S; Ahuja CK; Chakravarty K; Ray S; Mittal BR; Singh P; Lal V
    Mov Disord Clin Pract; 2021 Feb; 8(2):224-230. PubMed ID: 33553492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
    Meyer PT; Amtage F; Hellwig S
    Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
    Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
    Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.
    Buchert R; Buhmann C; Apostolova I; Meyer PT; Gallinat J
    Dtsch Arztebl Int; 2019 Nov; 116(44):747-754. PubMed ID: 31774054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
    Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
    Peralta C; Biafore F; Depetris TS; Bastianello M
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients.
    Toyoshima Y; Takahashi H; Katada S; Kojima N; Tada M; Tani T; Koike R; Nozawa T; Aida I; Nakajima T; Onodera O; Kakita A
    Neuropathology; 2021 Dec; 41(6):450-456. PubMed ID: 34779072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies.
    Trošt M; Perovnik M; Pirtošek Z
    Front Neurol; 2019; 10():1204. PubMed ID: 31798525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
    Schreckenberger M; Hägele S; Siessmeier T; Buchholz HG; Armbrust-Henrich H; Rösch F; Gründer G; Bartenstein P; Vogt T
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1128-35. PubMed ID: 15042325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging in Parkinson's disease.
    Pagano G; Niccolini F; Politis M
    Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.
    Liguori C; Ruffini R; Olivola E; Chiaravalloti A; Izzi F; Stefani A; Pierantozzi M; Mercuri NB; Modugno N; Centonze D; Schillaci O; Placidi F
    Parkinsonism Relat Disord; 2019 Jul; 64():97-105. PubMed ID: 30930059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.